FDA Makes Alzheimer’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.

PAM BELLUCK
Author: PAM BELLUCK

Advertisements
{ "slotId": "6845006044", "unitType": "responsive", "resize": "auto" }

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.